Sign in: Staff/Students
The University is to launch a dual PhD programme with National Tsing Hua University in Taiwan.
The institutions are launching 10 PhD scholarships in medicine and engineering which will enable students to spend at least 12 months in each institution. The scholarships, starting in October 2012, will provide tuition fees for a five-year PhD programme.
The scholarships include areas such as aeronautical engineering and the development of energy storage.
National Tsing Hua University is a member of the Top Research Universities Alliance in the Republic of China. The agreement is designed to establish a long-term research relationship between National Tsing Hua University and the University of Liverpool.
Eann Patterson, Professor of Structural Engineering and Mechanics at the University, said: “The dual PhD programme is the first step in a series of substantial collaborations that is likely to include joint MSc courses, undergraduate student exchanges and supporting one another’s recruitment programmes in secondary schools.”
You must be logged in to post a comment.
All recent news
Study highlights rising tide in adverse drug reactions
Daily testing saved city’s emergency services from Covid catastrophe
Large Hadron Collider takes first data in record-breaking run
Meet 10 Amazing #LivUniGrads
Liverpool physicists reflect on ten years since the Higgs boson discovery
Daily testing saved Liverpool's emergency services from Covid catastrophe - new findings published by @eClinicalMed revealed world’s first testing pilot saved almost 8,000 work days from being lost to self-isolation. Full story➡️http://bit.ly/3OZ2F9W #teamscience #teamliverpool
Today @CERN's #LargeHadronCollider will start delivering proton collisions to experiments at an unprecedented energy of 13.6 TeV.
Our @livuniphysics are part of the international collaboration that will collect & analyse the data ➡️http://bit.ly/3NSiVcc #LHCRun3
Study highlights rising tide in adverse drug reactions ➡️https://news.liverpool.ac.uk/2022/07/05/study-highlights-rising-tide-in-adverse-drug-reactions/